MTOR and Miyoshi myopathy: In MM the use of humanized anti-IGF-1R antibody IMC-A12 (ImClone) has been shown to act in synergy with mTOR inhibitors, bortezomib and melphalan, in MM models in vitro and in vivo (68,76).